Strategies for Scale-up & Scale-out

CELL AND GENE THERAPY INSIGHTS

December 2018

Strategies for Scale-up & Scale-out

Download PDF

Editorial

Critical considerations for allogeneic cell therapy scale up

Critical considerations for allogeneic cell therapy scale up

Sharon Grimster

18 December 2018

Research Article

Scale-up of a perfusion-based dendritic cell generation process

Scale-up of a perfusion-based dendritic cell generation process

A Kozbial, H Weinstein, S K Murthy et al.

18 December 2018

Expert Insight

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

The long road to affordability: a cost of goods analysis for an autologous CAR-T process

Katy Spink, Andrew Steinsapir

18 December 2018

Back to the future: where are we taking lentiviral vector manufacturing?

Back to the future: where are we taking lentiviral vector manufacturing?

18 December 2018

Translating cell and gene therapies to the clinic

Translating cell and gene therapies to the clinic

H Dave, D Saunders, N Zhang et al.

18 December 2018

Innovator Insight

Commercial Lessons for Clinical Success

Commercial Lessons for Clinical Success

Simon Ellison, Heidi Hagen, Christophe Suchet

19 December 2018

Interview

Biopharma scale-up lessons to learn for cell & gene therapy

Biopharma scale-up lessons to learn for cell & gene therapy

Towards commercial allogeneic cell therapy manufacturing

Towards commercial allogeneic cell therapy manufacturing

Maria Del Pilar Redondo

18 December 2018

Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Autologous T cell immunotherapy scale out manufacturing models – the biotech perspective

Nina Kotsopoulou

18 December 2018